{
  "retracted": false,
  "timestamp": 1591833600000,
  "updates": [
    {
      "timestamp": 1591848917616,
      "identifier": {
        "doi": "10.1007/s00280-020-04090-4"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s00280-017-3463-x"
  },
  "journal": "Cancer Chemotherapy and Pharmacology",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization"
}
